Search

everythinglearnresearchcommunity

for

Search:↓

A 3-month stay in space causes skin thinning, disrupts hair growth, and changes muscle-related genes in mice.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.

The model suggests that scalp tension could lead to hair loss, with factors like blood vessel hardening, enlarged oil glands, and poor microcirculation also playing a role. It also hints at a possible link between skull shape and baldness pattern.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Bimatoprost gel makes eyelashes grow longer, but may cause side effects and should be monitored by an eye doctor.

Researchers created a mouse model for Cushing's syndrome to study glucocorticoid excess and potential treatments.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

Heparin and protamine are promising in tissue repair and organ regeneration, including skin and hair.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Finasteride affects brain processes related to neurotransmission and metabolism, potentially helping with neuropsychiatric conditions.

The document explains how to do skin procedures, care after surgery, and when to use certain treatments.

The conclusion is that a systematic approach is key for treating symmetrical alopecia in dogs, but treatment may not always be necessary.

The water extract of Bituminaria bituminosa, high in phenolic compounds, shows strong antioxidant and enzyme inhibitory potential.

Certain immune cells are more common on the top of the head and might help predict or treat common hair loss.

Human hair follicle cells can be turned into neural stem cell-like cells, which might help treat brain diseases.

Topical spironolactone may help treat ocular graft-versus-host disease with minimal side effects.

Hair loss might be due to nerve issues, treatable with electric stimulation or acupuncture.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Cosmeceuticals may benefit skin health but need more research for efficacy and safety confirmation.

The document suggests that hair loss after stopping birth control may be similar to post-pregnancy hair loss and could recur with future pregnancies.

Isotretinoin affects trace element levels and requires monitoring of liver and kidney functions.

There is no cure for myotonic dystrophy type 1, so treatment focuses on managing symptoms and complications.

One cat with low thyroid hormone had growth issues, and another with high thyroid hormone had skin problems; both got better with treatment.

In June 2019, the stem cell research field saw major progress, including new clinical trials, FDA approvals, and industry collaborations.

Patients with one autoimmune disease should be checked for other autoimmune disorders.

Women over forty can maintain skin and hair health with lifestyle and dietary changes.